Literature DB >> 23881881

Consumption of new psychoactive substances in a Spanish sample of research chemical users.

Débora González1, Mireia Ventura, Fernando Caudevilla, Marta Torrens, Magi Farre.   

Abstract

OBJECTIVE: To know the pattern of use of new psychoactive substances (NPSs) in a Spanish sample of research chemical (RC) users and to deepen the RC user profile and risk reduction strategies employed.
METHODS: This study is a cross-sectional survey by means of a specific questionnaire. Recruitment was carried out at music festivals, at non-governmental organizations (NGOs), and through announcements on an online forum. Two RC user profiles were defined, according to whether they search information through online forums.
RESULTS: A total of 230 users participated. The most frequent RCs were hallucinogenic phenethylamines (2C-B 80.0%, 2C-I 39.6%) and cathinones (methylone 40.1%, mephedrone 35.2%). The most frequent combination of RC with other illegal drugs was with cannabis (68.6%) and 2C-B with MDMA (28.3%). Subjects who are consulting drug forums (group 1) use more RC, obtain RC by Internet, and use more frequently risk prevention strategies. Regarding the risk-reduction strategies in this group, users sought information concerning RC before consuming them (100%), used precision scales to calculate dosage (72.3%), and analyzed the contents before consumption (68.8%).
CONCLUSIONS: There is a specific RC user profile with extensive knowledge and consumption of substances, using different strategies to reduce risks associated to its consumption.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  2C-B; consumption patterns; new psychoactive substances; research chemicals

Mesh:

Substances:

Year:  2013        PMID: 23881881     DOI: 10.1002/hup.2323

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  10 in total

1.  The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.

Authors:  Nicholas B Miner; James P O'Callaghan; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicol Teratol       Date:  2017-02-16       Impact factor: 3.763

2.  Drugs of Abuse and Novel Psychoactive Substances at Outdoor Music Festivals in Colorado.

Authors:  Jacob Fox; Alexis Smith; Alexander Yale; Christopher Chow; Elsa Alaswad; Tracy Cushing; Andrew A Monte
Journal:  Subst Use Misuse       Date:  2017-11-17       Impact factor: 2.164

3.  Human Pharmacology of Mephedrone in Comparison with MDMA.

Authors:  Esther Papaseit; Clara Pérez-Mañá; Julián-Andrés Mateus; Mitona Pujadas; Francina Fonseca; Marta Torrens; Eulàlia Olesti; Rafael de la Torre; Magí Farré
Journal:  Neuropsychopharmacology       Date:  2016-05-20       Impact factor: 7.853

Review 4.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

5.  Acute Pharmacological Effects of 2C-B in Humans: An Observational Study.

Authors:  Esther Papaseit; Magí Farré; Clara Pérez-Mañá; Marta Torrens; Mireia Ventura; Mitona Pujadas; Rafael de la Torre; Débora González
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

6.  Characterization of a recently detected halogenated aminorex derivative: para-fluoro-4-methylaminorex (4'F-4-MAR).

Authors:  D Fabregat-Safont; X Carbón; M Ventura; I Fornís; F Hernández; M Ibáñez
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

7.  Mephedrone and Alcohol Interactions in Humans.

Authors:  Esther Papaseit; Clara Pérez-Mañá; Elizabeth B de Sousa Fernandes Perna; Eulalia Olesti; Julian Mateus; Kim Pc Kuypers; Eef L Theunissen; Francina Fonseca; Marta Torrens; Jan G Ramaekers; Rafael de la Torre; Magí Farré
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

8.  Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.

Authors:  James D Sexton; Charles D Nichols; Peter S Hendricks
Journal:  Front Psychiatry       Date:  2020-02-11       Impact factor: 4.157

9.  New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.

Authors:  Eliza Kurcevič; Rick Lines
Journal:  Harm Reduct J       Date:  2020-11-30

10.  Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions.

Authors:  Débora González; Marta Torrens; Magí Farré
Journal:  Biomed Res Int       Date:  2015-10-12       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.